← Back to news

Markets

Vail Resorts Stock Is Down 54% Over Five Years and the Weather Just Got Worse

Y

Ecolab Details $4.75B CoolIT Deal, Targets Q3 2026 Close and 20%+ Margins by 2027

Y

Dow on Track to Close in Correction

Y

Meta Set a $9 Trillion Target. Then Came a Wave of Bad News.

Y

Which Is the Better Consumer Staples ETF: Fidelity's FSTA or iShares' IYK?

Y

Shein Frames Circularity as Convenience; Experts Say That Misses the Point

Y

Watch for This Buy Signal Before Jumping Into Stocks. It's Right 9 Out of 10 Times.

Y

Dollar Advances as Iran War Rages

Y

Super Micro Computer Hit With Securities Fraud Lawsuit Amid Alleged China Sales Cover-Up And Nvidia Chip Smuggling Scandal

Y

Karman Tanks 14%: Opportunity or Warning for This Defense Darling

Y

Worried About a Market Downturn? How Retirees Can Protect Their Savings in 2026.

Y

Here's The Latest Group Of Stocks To Benefit From Soaring Energy Prices

Y

The Bears Are in Control of Palo Alto Networks Stock as Claude Mythos Renews AI Fears

Y

Crude Oil Surges on Fears of Iran War Escalation

Y

Cooler US Weather Forecasts Lift Nat-Gas Prices

Y

Google’s TurboQuant Shakes SanDisk. What Should You Do With SNDK Stock Now?

Y

Homebuying in America: “You can have what you want, you just got to really work for it”

Y

4 Signs You’re Falling Into the ‘Wealth Effect’ Trap

Y

BYD Stock Drops As 2025 Earnings Fall 19%. Will Tesla EV Rival Spring Back In A Flash?

Y

Guide to selling and buying a house at the same time

Y

Bitcoin Policy Institute Voices Strong Opposition to PARITY Act

Y

Meta Stock Slips 30% Below Highs. Should You Buy, Hold, or Sell Now?

Y

Claude Mythos Sends CrowdStrike Plunging. Should You Buy the Dip?

Y

CrowdStrike, Palo Alto Stocks Plummet. Blame Anthropic—Again.

Y

Ondas Inc. Flywheel Gains Momentum, Vertical Liftoff Imminent

Y

Netflix Is Raising Prices Again—Here's What The Streaming Giant's Plans Cost Now

Y

Stocks Are in Retreat After a Month of War. Here Are the Losers—And Winners

Y

Dana Unveils “Dana 2030” Plan: $10B Revenue Target, 15% EBITDA Goal, $2B Buyback Program

Y

U.S. endures weakest Treasury auctions in over 3 years as anxiety around Iran war grows

Y

122-year-old beauty giant sued by investors over fraud claims

Y

Ross Gerber Flags Micron Technology As 'Very Good Chip Company': Here's Why The Analyst Loves MU Stock That Has Rallied 300%

Y

Aker BP’s Earnings Slide Masks a Massive Growth Push

Y

IPO Stock Of The Week: Cruise Ship Leader Viking Tests Key Resistance Area Amid Market Weakness

Y

Higher Brazil Sugar Production Weighs on Prices

Y

Stock Of The Day: Top Growth And Defensive Stock Near Buy Point

Y

Up 215% YTD, This Small-Cap Stock Is Beating AI Stocks

Y

This Biotech Holds Up In Buy Zone Despite Falling Market

Y

Wall Street Says Microsoft Stock Has 89% Rebound Potential. Should You Buy the Dip Now?

Y

Jim Cramer on Corteva, Inc.: “I Would Continue to Own the Stock”

Y

Jim Cramer on BXP, Inc.: “I Just Don’t Want It”

Y

Jim Cramer Explains Why He Does Not Think “PENN Entertainment Is Going Anywhere”

Y

Jim Cramer on Applied Digital Corporation: “I Think They’re Good”

Y

Jim Cramer Blesses Rigel Pharmaceuticals as a Spec as “It’s Doing Better Than People Realize”

Y

Jim Cramer on Qnity Electronics: “I Think the Company, Which Sells Materials for Semis, Is Fantastic”

Y

Jim Cramer on Paychex: “This Is a Stock That Strangely Has Been Crushed By AI Disruption Worries, I Think They’re Overblown”

Y

Jim Cramer on Hinge Health: “This Is Actually a Really Good Time to Buy It”

Y

Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively”

Y

Jim Cramer on Bristol-Myers Squibb: “The Stock’s Recent Pullbacks Have Represented Terrific Buying Opportunities”

Y

Jim Cramer on Merck & Co.: “If We’re Really Going Into an Oil Shock-Induced Slowdown, I Think This One’s Likely an Outperformer””

Y

Jim Cramer on Pfizer: “I Just Need to Know Their Product Flow Better”

Y